Adaptive Biotechnologies Corporation
ADPT | NASDAQ
$27.84
-$0.02 (-0.07%)
Sep 22, 2026, 1:15 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -41.64 | -5.56 | -3.14 | -7.64 | -19.22 | -55.78 |
PEG Ratio | 0.65 | 0.18 | -0.06 | 0.24 | -0.51 | -0.44 |
PS Ratio | 8.90 | 4.93 | 4.15 | 5.88 | 25.52 | 78.86 |
PB Ratio | 11.26 | 4.35 | 2.29 | 2.35 | 6.52 | 10.44 |
P/FCF Ratio | -50.34 | -8.93 | -4.24 | -5.44 | -15.48 | -46.05 |
P/OCF Ratio | -53.58 | -9.27 | -4.53 | -5.92 | -20.43 | -51.84 |
OCF/S Ratio | -16.60 | -53.20 | -91.81 | -99.26 | -124.87 | -152.14 |
Debt / Equity Ratio | 1.28 | 0.44 | 0.32 | 0.23 | 0.19 | 0.15 |
Quick Ratio | 3.23 | 2.81 | 4.50 | 4.99 | 3.37 | 6.78 |
Current Ratio | 3.34 | 2.89 | 4.66 | 5.12 | 3.54 | 6.91 |
Asset Turnover | 0.54 | 0.33 | 0.26 | 0.22 | 0.17 | 0.09 |
Interest Coverage | -4.85 | -14.04 | -16.45 | -47.24 | n/a | n/a |
Return on Equity | -27.19% | -78.68% | -73.04% | -43.13% | -34.32% | -19.67% |
Return on Assets | -11.60% | -29.57% | -34.07% | -23.37% | -22.45% | -13.10% |
Return on Invested Capital | -13.09% | -36% | -38.98% | -26.48% | -25.65% | -15.06% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 74.24% | 59.72% | 55.63% | 68.75% | 68.06% | 77.10% |
Net Profit Margin | -21.48% | -89.12% | -132.29% | -108.03% | -134.30% | -148.63% |
Pretax Profit Margin | -21.47% | -89.18% | -132.32% | -108.13% | -134.31% | -148.63% |
Operating Profit Margin | -20.62% | -90.83% | -133.33% | -108.03% | -135.39% | -155.33% |
FCF Margin | -17.67% | -55.25% | -98.09% | -108.09% | -164.87% | -171.26% |
EBITDA Margin | -10.78% | -71.95% | -111.16% | -94.55% | -125.27% | -146.72% |
Add to Watchlist
Select watchlists to add or remove ADPT